text_1: Biogen multiple sclerosis drug Tecfidera wins European approval.
text_2: Biogen Idec Inc’s high profile new multiple sclerosis drug Tecfidera won European approval, the company said on Monday, opening the door for its launch in one of the world’s largest markets for MS treatments.